Profusa, Inc. (PFSA)
NASDAQ: PFSA · Real-Time Price · USD
0.5343
-0.0355 (-6.23%)
At close: Nov 6, 2026, 4:00 PM EST
0.5720
+0.0377 (7.06%)
Pre-market: Nov 9, 2026, 7:23 AM EST
Profusa Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
15
Market Cap
323.60K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 100.00K | 55.00K | 122.22% |
| Dec 31, 2023 | 45.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 742.00K | -3.20M | -81.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vivos Therapeutics | 20.90M |
| WORK Medical Technology Group LTD | 10.72M |
| Nuwellis | 9.01M |
| Beyond Air | 7.69M |
| INVO Fertility | 7.53M |
| Tenon Medical | 5.31M |
| 20/20 Biolabs | 2.04M |
| Co-Diagnostics | 721.39K |
PFSA News
- 25 days ago - Profusa receives ISO 13485:2016 certificate from GMED - TheFly
- 25 days ago - Profusa Receives ISO 13485:2016 Certificate from GMED - GlobeNewsWire
- 6 weeks ago - Why Is Penny Stock Profusa (PFSA) Up Today? - TipRanks
- 6 weeks ago - Profusa announces progress towards Lumee oxygen platform CE mark - TheFly
- 6 weeks ago - Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early October - GlobeNewsWire
- 7 weeks ago - Profusa regains Nasdaq compliance - TheFly
- 7 weeks ago - Profusa, Inc. Receives Nasdaq Compliance Determination - GlobeNewsWire
- 2 months ago - Profusa regains compliance with Nasdaq - TheFly